✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals
Market Cap
₹830 Cr.
P/E
88.16

Key Ratios

Market cap
Market cap
830 Cr
PE
PE
88.16
Prom Holding
Prom Holding
71.45 %
ROE (%)
ROE (%)
36.29
ROCE (%)
ROCE (%)
40.67
Div Yield (%)
Div Yield (%)
-
Sales
Sales
40.24 Cr
OPM (%)
OPM (%)
0.41 %
Debt to Equity
Debt to Equity
0.15

About

Gujarat Kidney and Super Speciality operates a chain of mid-sized multi-speciality hospitals, … Read more
Low
98
52W Range
High
123
  • Guj. Kidney & Super
  • Fortis MalarHospital
  • Yatharth Hospital

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

3 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Payment Mode

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)
    • Number of Outpatient Visits - Quarterly (.)

    Peer Comparison

    FAQs on Gujarat Kidney And Super Speciality Ltd. Business

    Gujarat Kidney and Super Speciality operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary (which are surgical services) and tertiary care (which are super speciality surgical services).

    Guj. Kidney & Super major competitors are Fortis MalarHospital, Yatharth Hospital, GPT Healthcare, Jupiter Life Line, Narayana Hrudayalay, KMC Speciality Hosp, Aster DM Healthcare.
    Market Cap of Guj. Kidney & Super is ₹820 Crs.
    While the median market cap of its peers are ₹5,807 Crs.

    Guj. Kidney & Super seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material